Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered

NCT05332340 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction Following Radical Prostatectomy
Erectile Dysfunction
Prostate Cancer
Radical Prostatectomy

Interventions

DRUG: BZ371A

Sponsor

Biozeus Biopharmaceutical S.A.

Collaborators

[object Object]